Herpes zoster vax cost effective in older adults in Belgium?

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.644, 2012-01, pp. : 6-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiviral Therapies for Herpes Zoster Infections: Are They Economically Justifiable?

By Smith K.J.

PharmacoEconomics, Vol. 18, Iss. 2, 2000-08 ,pp. : 95-104

Adis International

Access to resources Recommend Favorite

Home-Based Medication Review in Older People: Is it Cost Effective?

By Pacini Margaret Smith Richard D. Wilson Edward C.F. Holland Richard

PharmacoEconomics, Vol. 25, Iss. 2, 2007-01 ,pp. : 171-180

Adis International

Access to resources Recommend Favorite

Valsartan cost effective in HF?

Inpharma, Vol. 1, Iss. 1445, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Valsartan cost effective in HF?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 456, 2004-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

LMWHs cost effective for DVT?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 260, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite